Cigna Corporation

(New York Stock Exchange)
Slightly Bullish +15

Bradley Foster & Sargent Inc. CT Reduces Holdings in Cigna Group $CI

πŸ“‰ Bradley Foster & Sargent Inc. CT trimmed its Cigna Group holdings by 8.8% in Q1, reducing its stake to 18,132 shares valued at $4.837 million.

πŸ“ˆ Assetmark Inc. increased its position by 10.0% to own 65,662 shares worth $17.515 million following a purchase of 5,963 shares in Q1.

πŸš€ apricus wealth LLC expanded its Cigna Group stake by 715.9% in Q4, now holding 9,505 shares valued at $2.616 million.

πŸ“Š OFI Invest Asset Management significantly increased its position by 8,357.8% in Q4, acquiring 32,679 shares for a total value of $9.102 million.

πŸ’° Cigna Group announced a quarterly dividend of $1.56 per share with an ex-dividend date of September 8th and a yield of 2.2%.

πŸ“‰ CEO David Cordani sold 201,878 shares for approximately $59.1 million under a Rule 10b5-1 trading plan on May 12th.

πŸ“‰ CAO Jamie G. Kates reduced her share count by 27.52% in a transaction worth $268,450 executed on June 12th.

πŸ” Sanford C. Bernstein raised its price target to $381.00 and maintained an 'outperform' rating in a July 9th report.

⚠️ Barclays downgraded Cigna Group from 'overweight' to 'equal weight' and lowered its price objective to $304.00 on May 26th.

πŸ“ˆ The consensus analyst price target for Cigna Group is $338.80 with an average rating of 'Moderate Buy'.

Bullish Signals
  • Assetmark Inc. increased its stake in Cigna Group by 10.0% in the first quarter, purchasing an additional 5,963 shares.
  • apricus wealth LLC grew its holdings in Cigna Group by 715.9% during the fourth quarter, adding 8,340 shares.
  • OFI Invest Asset Management increased its position in Cigna Group by 8,357.8% in the fourth quarter, buying 32,679 additional shares.
  • Sanford C. Bernstein raised its price target on Cigna Group from $371.00 to $381.00 and assigned an 'outperform' rating.
  • Royal Bank Of Canada increased its target price on Cigna Group from $333.00 to $337.00 with an 'outperform' rating.
  • Cigna Group maintains a dividend yield of 2.2% with a payout ratio of 26.45%, providing regular income to shareholders.
Risk Factors
  • Bradley Foster & Sargent Inc. CT reduced its holdings in Cigna Group by 8.8% in the first quarter, selling 1,747 shares.
  • Barclays downgraded Cigna Group from an 'overweight' rating to an 'equal weight' rating and lowered its price objective to $304.00.
  • CEO David Cordani sold 201,878 shares for a total transaction of $59,113,915.96, representing an 85.46% decrease in his ownership.
  • CAO Jamie G. Kates sold 899 shares for $268,450.39, resulting in a 27.52% decrease in her position.
Full Analysis
Bradley Foster & Sargent Inc. CT reduced its holdings in Cigna Group (NYSE: CI) by 8.8% during the first quarter, selling 1,747 shares to bring its total position to 18,132 shares valued at $4.837 million. This move contrasts with several other institutional investors who increased their stakes in the fourth quarter, including Assetmark Inc., which added 5,963 shares for a total value of $17.515 million, and apricus wealth LLC, which grew its position by 715.9% to own 9,505 shares worth $2.616 million. Analyst sentiment regarding Cigna Group remains mixed with varying price targets and ratings from major financial institutions. Sanford C. Bernstein raised its price target to $381.00 with an 'outperform' rating, while Barclays downgraded the stock to 'equal weight' and lowered its objective to $304.00. The consensus average price target stands at $338.80 based on a Moderate Buy rating from MarketBeat data. Cigna Group recently announced a quarterly dividend of $1.56 per share, payable on September 23rd to stockholders of record as of September 8th, representing a 2.2% yield. Insider trading activity includes CEO David Cordani selling over $59 million in shares under a pre-arranged plan and CAO Jamie G. Kates reducing her position by 27.52%. The company maintains a market capitalization of $76.73 billion with a P/E ratio of 12.30.